Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > The share prices says what the market thinks

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jul 01, 2021 3:57am

131 Views

Post# 33478426

RE:RE:RE:RE:RE:RE:RE:RE:RE:The share prices says what the market thinks

Call the company and ask what progress has been made on hemo. Ask them for a high level timeline of milestones to get thyroid into the clinic and estimated costs. It's not crazy as shareholders to expect this basic info. Let me know how it goes and that will answer your question.